PulseAugur
EN
LIVE 07:13:39

AI system PRECEDE aids drug redesign by mitigating side effects

Researchers have developed PRECEDE, an AI system designed to assist in drug redesign by focusing on mitigating side effects while maintaining therapeutic efficacy. This system operates as a co-scientist, utilizing evidence-based reasoning over drug-side-effect associations, biomedical knowledge graphs, and safety-driven optimization precedents. PRECEDE is structured as a human-supervised workflow, ensuring that hypotheses are auditable, falsifiable, and grounded in existing pharmacological knowledge. AI

IMPACT Could accelerate the development of safer and more effective pharmaceuticals by improving the drug redesign process.

RANK_REASON Research paper detailing a novel AI system for drug redesign. [lever_c_demoted from research: ic=1 ai=1.0]

Read on arXiv cs.AI →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

AI system PRECEDE aids drug redesign by mitigating side effects

COVERAGE [1]

  1. arXiv cs.AI TIER_1 English(EN) · Yujin Kim, Charmgil Hong ·

    A Precedent-Guided Co-Scientist for Side-Effect-Aware Drug Redesign

    arXiv:2607.02944v1 Announce Type: cross Abstract: We propose PRECEDE, a precedent-guided co-scientist for side-effect-aware drug redesign that revises a parent compound to mitigate a specified side effect while preserving therapeutic function. Rather than isolated molecular gener…